Nexo Therapeutics
PrivateLast Round
Series A
Jul 26, 2023
Total Funding Raised
$60M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nexo Therapeutics operates in Healthcare & Life Sciences and is based in Littleton, Colorado. Its latest recorded funding round was a Series A round in July 2023.
Nexo Therapeutics is a biotechnology company that develops small-molecule therapies for oncology patients using a covalent ligand discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nexo Therapeutics Comparables
Compare Nexo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Totus Medicines | 89% | |
| Covant Therapeutics | 87% | |
| BridGene Biosciences | 87% |
For institutional investors. Book with your work email.
Nexo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 26, 2023 | ||||
| Series B | Nov 15, 2022 |
For institutional investors. Book with your work email.
Nexo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Enterprise Associates | Series A |
| Cormorant Asset Management | Series A |
| Versant Ventures | Series A |
| Cormorant Asset Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 41% MoM, reaching 2.2K.
- Apr 17, 2026
Monthly visitors grew 64% MoM.
For institutional investors. Book with your work email.
Nexo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nexo Therapeutics's valuation, stock price, and market status.
Is Nexo Therapeutics a public or private company?
Nexo Therapeutics is a private company.
What is the current stock price of Nexo Therapeutics?
Nexo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nexo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nexo Therapeutics worth (valuation)?
Valuation information for Nexo Therapeutics is not publicly available.
Can I buy Nexo Therapeutics stock?
Nexo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nexo Therapeutics's last funding round?
Nexo Therapeutics's most recent funding round was Series A on July 26, 2023.
Who are the main investors in Nexo Therapeutics?
Key investors in Nexo Therapeutics include Versant Ventures.
Will Nexo Therapeutics IPO soon?
No public IPO plans have been announced for Nexo Therapeutics.
How can I track Nexo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nexo Therapeutics's shares on secondary markets.